A study published in the official journal of the Heart Rhythm Society reports what may be the first recorded case of acute cardiovascular issues related to the use of cannabidiol and cannabigerol (CBD/CBG)-containing supplements, according to its authors.
US Cardiac Arrhythmia Case Could Stoke International CBD Safety Worries
A patient admitted to a US emergency department after experiencing dizziness and fainting without warning is found to have been using a cocktail of herbal dietary supplements, including CBD and CBG. The case could fuel international worries about CBD's safety, for example in the EU, where novel food applications were recently put on hold by EFSA because of safety data gaps.
